Basic Information

Trademark/Trade Name Biqi-Montmorillonite Powder Product Type Digestive System Drug Product Patent Number Approval Number National Drug Approval Number H19990307

Production Manufacturer Hainan Xiance Pharmaceutical Co., Ltd. Dosage form Oral powder Specifications: 3 grams per bag, 10 bags/6 bags per box Ingredients: Each bag of this product contains 3 grams of main ingredient montmorillonite, and excipients are glucose, aspartame, and vanillin . Usage and Dosage: Oral, 1 bag (3g) for adults, 3 times a day. Children under 1 year old take 1 bag a day, divided into 3 times; children aged 1-2 years old take 1-2 bags a day, divided into 3 times; children over 2 years old take 2-3 bags a day, divided into 3 times, and take this product Pour into half a cup of warm water (about 50 ml), mix well and drink quickly. Product Performance for Treating Acute and Chronic Diarrhea in Adults and Children. This product is a natural montmorillonite particle powder with a lamellar structure and non-uniform charge distribution. It has a strong effect on viruses, bacteria and the toxins and gases produced in the digestive tract. It has fixed and inhibitory effects, making it lose its pathogenic effect; in addition, it also has a strong ability to cover and protect the mucosa of the digestive tract, repair and improve the defense function of the mucosal barrier against attacking factors, and has the function of balancing normal flora and local analgesic effects.

Edit Features of this paragraph

Biqi; It has the dual functions of removing pathogens and protecting the gastric and intestinal mucosa. It does not affect the absorption and utilization of other drugs and can be used in combination with ORS and other drugs; It is not absorbed into the blood, has high safety, and is suitable for various patients. It tastes sweet and has good patient compliance. Product Description: Biqi; Montmorillonite Powder is a national Class IV new drug produced by Hainan Simcere Pharmaceutical Co., Ltd., and the drug approval number is (National Drug Approval Number H19990307). It is the first pharmaceutical company in Hainan Province to pass GMP certification as a whole. In 2001, Hainan Xiancere Pharmaceutical Co., Ltd. was listed as a "Key High-tech Enterprise in the National Torch Plan". Biqi; Montmorillonite powder is a green medicine from nature. It is a digestive tract pathogen removal and mucosal protective agent. It can not only protect the intestinal mucosa from attacks by pathogenic factors, strengthen the repair and regeneration of damaged mucosa, and improve The body's own disease resistance ability can also fix and eliminate various types of endogenous and exogenous attack factors, which has the advantage of dual effects. EU GMP Certification On April 19, 2010, BiQi's active ingredient, montmorillonite API, passed the EU GMP certification, which enabled Xiancere to sell montmorillonite API in EU countries. Previously, Simcere Pharmaceuticals had produced and sold montmorillonite powder preparations and APIs in China under the "Biqi" brand for many years. Montmorillonite powder is a leading anti-diarrheal drug in the domestic and foreign markets. This type of medicine is derived from natural minerals. Simcere has a high-quality, abundant montmorillonite mine in China.